Latest AI and machine learning research in pancreatic diseases for healthcare professionals.
INTRODUCTION AND OBJECTIVES: Steatotic liver disease (SLD) is a leading cause of liver disease worldwide. Itsstratified into metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction and alcohol-associated liver disease (MetALD), and alcohol-associated liver disease (ALD) based on self-reported alcohol use remains a challenge. We developed the Steatosis Liver Index (S...
Pancreatic ductal adenocarcinoma (PDAC) remains a formidable malignancy characterized by late diagnosis, high recurrence rates, and pronounced chemoresistance. While nanoparticle-based drug delivery systems (NDDS) offer theoretical advantages over conventional therapies, their clinical translation in PDAC has been severely limited. The dense desmoplastic stroma, elevated interstitial fluid pressur...
BACKGROUND: The country-level co-burden of esophageal cancer and lip and oral cavity cancer (LOC) among older adults remains poorly characterised. We ...
Methanol-water mixtures find use in many applications, particularly catalytic energy conversion processes. Their importance has motivated numerous com...
Pancreatic adenocarcinoma (PAAD) remains one of the most lethal cancers, largely due to the lack of reliable diagnostic biomarkers. Through integrativ...
BACKGROUND: There is increasing recognition that trauma exposure and related psychiatric consequences predict cardiovascular disease risk. However, mo...
IMPORTANCE: Early liver metastasis (early-LiM) after pancreatectomy represents an aggressive biological phenotype of pancreatic ductal adenocarcinoma ...
Gastrointestinal (GI) cancers, including colorectal, gastric, pancreatic, hepatocellular, and esophageal malignancies, remain a leading cause of cance...
BACKGROUND/AIM: Risky alcohol use is common among university students and negatively impacts physical and psychosocial health. Current screening instr...
BACKGROUND: Lung cancer is a leading cause of cancer-related mortality, and its prognosis is often affected by comorbidities such as type 2 diabetes m...
BACKGROUND: Family history of pancreatic cancer (PC), pathogenic germline variants (PGVs), and increased intrapancreatic fat (IPF) are individually as...
BACKGROUND: Pancreatic cancer Volumetric Modulated Arc Therapy (VMAT) planning presents a significant dosimetric challenge due to the high-dose gradie...
The hepatitis C virus is a significant global health concern and a major cause of chronic liver disease. Therefore, developing a mathematical model is...
OBJECTIVES: Acute pancreatitis (AP) carries a high mortality risk in ICU patients. The glucose-to-albumin ratio (GAR), reflecting metabolic stress and...
Chronic liver diseases are an increasing cause of morbidity and mortality in Latin America, driven by the convergence of alcohol and metabolic-associa...
Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction and alcohol-related liver disease (MetALD) exist on a conti...
BACKGROUND AND AIMS: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies worldwide because most patients are diagnosed...
PURPOSE: To evaluate whether deep learning-based segmentation can improve visualization and diagnostic interpretation of MR cholangiopancreatography (...
Fricke gel dosimeters, also known as hydrogels, have emerged as attractive tools in clinical dosimetry due to the requirements of quality assurance pr...
RATIONALE AND OBJECTIVES: To address the challenge of preoperative prediction of synchronous liver metastasis (LM) in pancreatic cancer (PC), we devel...